Details of Drug Interaction

Details of Drug-Drug Interaction

 Drug General Information (ID: DDI4COMV3W)
  Drug Name Terazosin Drug Info Budesonide Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antineoplastics Antiinflammatory Agents
  Structure

 Mechanism of Terazosin-Budesonide Interaction (Severity Level: Moderate)
     Antagonize the effect of antihypertensive agents Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Terazosin Budesonide
      Mechanism Antihypertensive agent
Alpha-1 adrenergic receptor  Antagonist 		Hypertensive effects
Induction of sodium and fluid retention 
      Key Mechanism Factor 1
Factor Name Adrenergic receptor alpha-1 Structure Sequence
Protein Family G-protein coupled receptor 1 family
Protein Function
This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate phenylephrine(PE)-stimulated ERK signaling in cardiac myocytes.
    Click to Show/Hide
      Mechanism Description
  • Antagonize the effect of Terazosin when combined with Budesonide 

Recommended Action
      Management Patients on prolonged (i.e., longer than about a week) or high-dose corticosteroid therapy should have blood pressure, electrolyte levels, and body weight monitored regularly, and be observed for the development of edema and congestive heart failure. The dosages of antihypertensive medications may require adjustment.

References
1 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
2 Multum Information Services, Inc. Expert Review Panel.